Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (1065)	3/10/2006 4:43:54 PM
From: Icebrg	Read Replies (2) \| Respond to of 1255

Harry Time will tell. I believe he knows more about these things than most on that board. Actually, I also had him on ignore to start with, but he slipped through the net once and I allowed him to stay in sight. I find it interesting to try to figure out if he really has a message or not. Being right once is ok, but there is a 50 % chance for a hit. We'll see if he hits with his second strike too. He feels that the Organon schizophrenia trial will do well too, with the best results seen among refractory patients. I don't think an ordinary board member would even think of making that kind of "prediction". If he hits that one, I can only say Urk, Urk. Evidently, he is also reading the SI boards. Maybe he will turn up here too and share his intuitions (or tradecraft?). Erik